Delivery Order SPE2DB20D3103-SPE2DB24FM2N9
Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $9,782.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,416,379 units of Ondansetron HCL 4 mg Tablets in 30-count packages. This is a delivery order contract with a firm fixed-price pricing type, with a completion date of April 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,774,936 units of Ondansetron HCL 4 mg tablets. The award, valued at $2,928.70, is a delivery order with a firm fixed price. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $10,624.15, was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a delivery order for the supply of 4,559,022,633 units of 4 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price pricing type and an ultimate completion date of November 8, 2022. It is not designated as a set-aside contract....
- This federal contract award, valued at $4,235.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,559,735,862 units of the pharmaceutical product Ondansetron HCL 4 mg Tablet in 30-count packages. The contract has a completion date of January 27, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $4,646.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,105,874 units of the pharmaceutical drug Ondansetron HCL 4 mg Tablet. The contract has a completion date of December 15, 2023 and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $3,379.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,993,787 units of Ondansetron ODT 4 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $32,981.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,611,530 units of Ondansetron HCl 8 mg tablets in 30s packaging. This is a firm-fixed price delivery order contract with a completion date of July 27, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $15,333.05, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of 4,563,445,246 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 26, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award....
- This federal contract award, valued at $2,842.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with an ultimate completion date of October 12, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $25,982.21, is for the delivery of 4,563,219,741 tablets of Ondansetron HCL 4 mg, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...